Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ELWT vs NTHI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ELWT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–3 Matrix Metrics)

ELWT Overall Winner 6-Pillar Tally: ELWT 3 – 2 NTHI (1 Tie) Matrix Metrics: ELWT 4 – 3 NTHI

As of Nov 20, 2026, ELWT (ELWT) is the stronger overall head-to-head candidate over NeOnc Technologies Holdings, Inc. (NTHI) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). ELWT carries a Unified Composite Score of 51.7/100 (HOLD) at $2.97 (N/M Forward P/E, -55.0% operating margin), whereas NTHI carries 35.6/100 (SELL) at $3.15 (N/M Forward P/E, -101667.5% operating margin).

  • Technical & Structure Timing Caution: ELWT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3); meanwhile NTHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ELWT vs NTHI
ELWT US Equity Head-to-Head Winner
ELWT
Institutional Equity
$2.97
-2.94% 1D
Market Cap $20.3M
TTM Revenue $19M
Forward P/E N/M
Beta / 30D Vol 1.20β · 88% Vol
Unified Composite Score
51.7 / 100 HOLD
Tech 60.0 Fund 52.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -21.6%), weak momentum, RSI 23
RSI-14: 23.3 · SMA20: $3.83 · SMA50: $5.37
NTHI NASDAQ
NeOnc Technologies Holdings, Inc. Common Stock
Pharmaceutical Preparations
$3.15
-9.48% 1D
Market Cap $100.4M
TTM Revenue $39,990
Forward P/E N/M
Beta / 30D Vol 0.64β · 127% Vol
Unified Composite Score
35.6 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 42
RSI-14: 42.2 · SMA20: $3.66 · SMA50: $3.29

6-Pillar Scorecard Institutional Category Breakdown (ELWT 3 – 2 NTHI)

Columns: Metric · ELWT · NTHI
1. Valuation Multiples ELWT
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 1.1x N/M
2. Growth & Scale ELWT
Revenue Growth (YoY) +6.6% -100.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $19M $39,990
Market Cap $20.3M $100.4M
3. Profitability & Quality NTHI
Gross Margin 10.0% 100.0%
Operating Margin -55.0% -101667.5%
Net Profit Margin -55.6% 0.0%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow NTHI
Cash Generation (TTM) N/A -$22M
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE $207,452 Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ELWT
OpEx & R&D Intensity 65.0% of Rev ($12M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Telecom Services Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ELWT (4) vs NTHI (3)
Institutional Metric ELWT NTHI Criterion Row Edge
Market Capitalization
Scale
$20.3M $100.4M Larger Scale NTHI
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+6.6% -100.0% Higher Growth ELWT
Operating Margin (TTM)
Profitability
-55.0% -101667.5% Higher Margin ELWT
Net Profit Margin
Profitability
-55.6% 0.0% Higher Margin NTHI
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
5% ($3–$10) 7% ($2–$11) Stronger Trend NTHI
Beta / 30D Volatility
Risk Regime
1.20β · 88% Vol 0.64β · 127% Vol Lower Realized Risk ELWT
Unified Institutional Score
Composite Signal
51.7 / 100 (HOLD) 35.6 / 100 (SELL) Higher Composite ELWT
Trailing 12M Revenue (USD)
Operating Scale
$19M $39,990 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
10.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) -$22M ($207,452 Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NTHI +51.73 pp
ELWT: -44.95% · NTHI: +6.78%
3M Horizon NTHI +28.54 pp
ELWT: -60.51% · NTHI: -31.97%
6M Horizon NTHI +20.12 pp
ELWT: -62.64% · NTHI: -42.52%
1Y Horizon NTHI +7.21 pp
ELWT: -60.4% · NTHI: -53.19%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELWT vs NTHI. Trailing 12-month operating profitability (ELWT -55.0% vs NTHI -101667.5%) and valuation multiples (ELWT N/M vs NTHI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ELWT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$19M
Gross Margin10.0%
Op. Margin-55.0%
ROE / Fwd P/E0.0% · N/M
NTHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$39,990
Gross Margin100.0%
Op. Margin-101667.5%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ELWT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ELWT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NTHI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NTHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ELWT Moat Profile Cyclical / Execution-Driven Positioning
Telecom Services Operator
Competes within the Telecom Services value chain with $20.3M market capitalization and -55.0% operating margin.
OpEx & R&D Reinvestment 65.0% of Rev ($12M)
90D Engineering Disclosures 0 Published
NTHI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $100.4M market capitalization and -101667.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ELWT vs NTHI Key Questions & Quantitative Answers

As of Nov 20, 2026, ELWT (ELWT) is the stronger overall head-to-head candidate over NeOnc Technologies Holdings, Inc. (NTHI) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). ELWT carries a Unified Composite Score of 51.7/100 (HOLD) at $2.97 (N/M Forward P/E, -55.0% operating margin), whereas NTHI carries 35.6/100 (SELL) at $3.15 (N/M Forward P/E, -101667.5% operating margin). Technical & Structure Timing Caution: ELWT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3); meanwhile NTHI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ELWT leads the Growth & Scale pillar: ELWT posts +6.6% YoY revenue growth and +0.0% YoY earnings growth on $19M TTM revenue (10.0% gross margin, -55.0% operating margin), compared with NTHI at -100.0% YoY revenue growth and +0.0% YoY earnings growth on $39,990 TTM revenue (100.0% gross margin, -101667.5% operating margin). On trailing 12-month operating scale, ELWT generates $19M in USD-normalized revenue versus $39,990 for NTHI. In operating R&D and SG&A reinvestment, ELWT deploys 65.0% of Rev ($12M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NTHI.

ELWT screens cheaper on headline valuation multiples. ELWT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.1x EV/Revenue (unreported cash flow margin), whereas NTHI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELWT (0.0% ROE) versus NTHI (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, ELWT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.20β · 88% Vol realized risk). By comparison, NTHI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.64β · 127% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.